117 related articles for article (PubMed ID: 22114240)
1. Magnetization transfer contrast-prepared MR imaging of the liver: inability to distinguish healthy from cirrhotic liver.
Rosenkrantz AB; Storey P; Gilet AG; Niver BE; Babb JS; Hajdu CH; Lee VS
Radiology; 2012 Jan; 262(1):136-43. PubMed ID: 22114240
[TBL] [Abstract][Full Text] [Related]
2. Systematic variation of off-resonance prepulses for clinical magnetization transfer contrast imaging at 0.2, 1.5, and 3.0 tesla.
Martirosian P; Boss A; Deimling M; Kiefer B; Schraml C; Schwenzer NF; Claussen CD; Schick F
Invest Radiol; 2008 Jan; 43(1):16-26. PubMed ID: 18097273
[TBL] [Abstract][Full Text] [Related]
3. Magnetization transfer contrast imaging of liver cirrhosis.
Chen JH; Chai JW; Shen WC
Hepatogastroenterology; 1999; 46(29):2872-7. PubMed ID: 10576364
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of fibrotic liver disease with whole-liver T1ρ MR imaging: a feasibility study at 1.5 T.
Allkemper T; Sagmeister F; Cicinnati V; Beckebaum S; Kooijman H; Kanthak C; Stehling C; Heindel W
Radiology; 2014 May; 271(2):408-15. PubMed ID: 24475807
[TBL] [Abstract][Full Text] [Related]
5. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
6. Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study.
Luciani A; Vignaud A; Cavet M; Nhieu JT; Mallat A; Ruel L; Laurent A; Deux JF; Brugieres P; Rahmouni A
Radiology; 2008 Dec; 249(3):891-9. PubMed ID: 19011186
[TBL] [Abstract][Full Text] [Related]
7. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography.
Asbach P; Klatt D; Schlosser B; Biermer M; Muche M; Rieger A; Loddenkemper C; Somasundaram R; Berg T; Hamm B; Braun J; Sack I
Radiology; 2010 Oct; 257(1):80-6. PubMed ID: 20679447
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
[TBL] [Abstract][Full Text] [Related]
9. Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations--preliminary MR imaging in rats.
Kim H; Booth CJ; Pinus AB; Chen P; Lee A; Qiu M; Whitlock M; Murphy PS; Constable RT
Radiology; 2008 Jun; 247(3):696-705. PubMed ID: 18403622
[TBL] [Abstract][Full Text] [Related]
10. Whole-body magnetization transfer contrast imaging.
Boss A; Martirosian P; Küper K; Fierlbeck G; Claussen CD; Schick F
J Magn Reson Imaging; 2006 Nov; 24(5):1183-7. PubMed ID: 17031816
[TBL] [Abstract][Full Text] [Related]
11. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences.
Girometti R; Furlan A; Esposito G; Bazzocchi M; Como G; Soldano F; Isola M; Toniutto P; Zuiani C
J Magn Reson Imaging; 2008 Aug; 28(2):411-9. PubMed ID: 18666139
[TBL] [Abstract][Full Text] [Related]
12. Cerebral white matter: technical development and clinical applications of effective magnetization transfer (MT) power concepts for high-power, thin-section, quantitative MT examinations.
Finelli DA; Hurst GC; Amantia P; Gullapali RP; Apicella A
Radiology; 1996 Apr; 199(1):219-26. PubMed ID: 8633148
[TBL] [Abstract][Full Text] [Related]
13. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T--preliminary results.
Marin D; Soher BJ; Dale BM; Boll DT; Youngblood RS; Merkle EM
Radiology; 2010 Jan; 254(1):179-87. PubMed ID: 20032151
[TBL] [Abstract][Full Text] [Related]
14. Magnetization transfer in human Achilles tendon assessed by a 3D ultrashort echo time sequence: quantitative examinations in healthy volunteers at 3T.
Syha R; Martirosian P; Ketelsen D; Grosse U; Claussen CD; Schick F; Springer F
Rofo; 2011 Nov; 183(11):1043-50. PubMed ID: 21986866
[TBL] [Abstract][Full Text] [Related]
15. Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.
Tamada T; Ito K; Sone T; Kanki A; Sato T; Higashi H
Eur J Radiol; 2011 Dec; 80(3):e207-11. PubMed ID: 20869827
[TBL] [Abstract][Full Text] [Related]
16. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
[TBL] [Abstract][Full Text] [Related]
17. Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients.
Gouya H; Vignaux O; Sogni P; Mallet V; Oudjit A; Pol S; Legmann P
Radiology; 2011 Oct; 261(1):144-55. PubMed ID: 21771955
[TBL] [Abstract][Full Text] [Related]
18. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
[TBL] [Abstract][Full Text] [Related]
19. Portal vein and its tributaries: evaluation with thin-section three-dimensional contrast-enhanced dynamic fat-suppressed MR imaging.
Ito K; Blasbalg R; Hussain SM; Mitchell DG
Radiology; 2000 May; 215(2):381-6. PubMed ID: 10796911
[TBL] [Abstract][Full Text] [Related]
20. Thalamic damage and long-term progression of disability in multiple sclerosis.
Rocca MA; Mesaros S; Pagani E; Sormani MP; Comi G; Filippi M
Radiology; 2010 Nov; 257(2):463-9. PubMed ID: 20724544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
